Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (211-220 of 269) with videos related to

Pageof 27
Sort By:
Plos One|February 2, 2013
Method for quantitative study of airway functional microanatomy using micro-optical coherence tomographyLinbo Liu, Kengyeh K Chu, Grace H Houser, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense MutationsVenkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 7, 2025
Lumacaftor inhibits channel activity of rescued F508del cystic fibrosis transmembrane conductance regulatorAdam D Ambrosetti, Zachary J Hagedorn, Taylor R Bono, et al.
American Journal of Respiratory Cell and Molecular Biology|October 16, 2014
Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungsNicholas W Keiser, Susan E Birket, Idil A Evans, et al.
Frontiers in Physics|November 16, 2022
Minimally Invasive Image-Guided Gut Transport Function Measurement ProbeDavid O Otuya, Evangelia Gavgiotaki, Camella J Carlson, et al.
International Journal of Molecular Sciences|March 11, 2023
Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)Amna Siddiqui, Halil Dundar, Jyoti Sharma, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 17, 2019
Evaluation of 1,2,3-Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX-770 and VX-809Jake E Doiron, Christina A Le, Britton K Ody, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 6, 2021
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutationYifat S Oren, Michal Irony-Tur Sinai, Anita Golec, et al.
Plos One|October 13, 2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule TherapeuticsW Joon Chung, Jennifer L Goeckeler-Fried, Viktoria Havasi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2026
Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDOMeghan Shirley Bezerra, Babette S Zemel, Robert J Gallop, et al.
Pageof 27

Showing results (211-220 of 269) with videos related to

Sort By:
Pageof 27
Plos One|February 2, 2013
Method for quantitative study of airway functional microanatomy using micro-optical coherence tomographyLinbo Liu, Kengyeh K Chu, Grace H Houser, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense MutationsVenkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 7, 2025
Lumacaftor inhibits channel activity of rescued F508del cystic fibrosis transmembrane conductance regulatorAdam D Ambrosetti, Zachary J Hagedorn, Taylor R Bono, et al.
American Journal of Respiratory Cell and Molecular Biology|October 16, 2014
Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungsNicholas W Keiser, Susan E Birket, Idil A Evans, et al.
Frontiers in Physics|November 16, 2022
Minimally Invasive Image-Guided Gut Transport Function Measurement ProbeDavid O Otuya, Evangelia Gavgiotaki, Camella J Carlson, et al.
International Journal of Molecular Sciences|March 11, 2023
Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)Amna Siddiqui, Halil Dundar, Jyoti Sharma, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 17, 2019
Evaluation of 1,2,3-Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX-770 and VX-809Jake E Doiron, Christina A Le, Britton K Ody, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 6, 2021
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutationYifat S Oren, Michal Irony-Tur Sinai, Anita Golec, et al.
Plos One|October 13, 2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule TherapeuticsW Joon Chung, Jennifer L Goeckeler-Fried, Viktoria Havasi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2026
Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDOMeghan Shirley Bezerra, Babette S Zemel, Robert J Gallop, et al.
Pageof 27